p16(INK4A) as a predictive factor in patients with locally advanced breast cancer treated with neoadjuvant doxorubicin monotherapy

Lignende værker

• Relation of gene expression-based tumor subclasses to clinical phenotypes
  af: Sørlie, T, et al.
  Udgivet: (2000)
• DNA methylation profiling in doxorubicin treated primary locally advanced breast tumours identifies novel genes associated with survival and treatment response
  af: Dejeux, Emelyne, et al.
  Udgivet: (2010)
• Studies of TP53 haplotypes in relation to LOH and TP53 mutations in breast cancer patients
  af: Langerød, A, et al.
  Udgivet: (2000)
• HER-2 activation and TP53 inactivation as predictors of survival in breast cancer
  af: Andersen, TI, et al.
  Udgivet: (2000)
• Screening breast cancer patients for Norwegian ATM mutations
  af: Laake, K, et al.
  Udgivet: (2000)